Evidence map›Paper›PMID 34666107›Full record

ArticleInternational journal of psychophysiology : official journal of the International Organization of Psychophysiology2021

Task switching reveals abnormal brain-heart electrophysiological signatures in cognitively healthy individuals with abnormal CSF amyloid/tau, a pilot study.

Rebecca Johnson Arechavala, Roger Rochart, Robert A Kloner, Anqi Liu, Daw-An Wu, Shao-Min Hung, Shinsuke Shimojo, Alfred N Fonteh, Michael T Kleinman, Michael G Harrington and 1 more

Open access · hybridAbstract read
In one paragraph

Article in International journal of psychophysiology : official journal of the International Organization of Psychophysiology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
0.8field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it, 9 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 5 institutions in 1 country.

Rebecca Johnson ArechavalaUniversity of California Irvine, Irvine, CA 92697-1830, USA.
Roger RochartNeurosciences, Huntington Medical Research Institutes, Pasadena, CA 91105, USA.
Robert A KlonerCardiovascular Research, Huntington Medical Research Institutes, Pasadena, CA 91105, USA; Division of Cardiovascular Medicine, Dept of Medicine, Keck School of Medicine at University of Southern California, Los Angeles, CA 90033, USA.
Anqi LiuDepartment of Computing and Mathematical Sciences (CMS), California Institute of Technology, Pasadena, CA 91125, USA; Department of Computer Science, Whiting School of Engineering, Johns Hopkins University, Baltimore, MD 21218, USA.
Daw-An WuDivision of Biology and Biological Engineering, California Institute of Technology, Pasadena, CA 91125, USA.
Shao-Min HungDivision of Biology and Biological Engineering, California Institute of Technology, Pasadena, CA 91125, USA.
Shinsuke ShimojoDivision of Biology and Biological Engineering, California Institute of Technology, Pasadena, CA 91125, USA.
Alfred N FontehNeurosciences, Huntington Medical Research Institutes, Pasadena, CA 91105, USA.
Michael T KleinmanUniversity of California Irvine, Irvine, CA 92697-1830, USA.
Michael G HarringtonNeurology, Keck School of Medicine at University of Southern California, Los Angeles, CA 90033, USA.
Xianghong ArakakiNeurosciences, Huntington Medical Research Institutes, Pasadena, CA 91105, USA. Electronic address: xianghong@hmri.org.
California Institute of Technology · USHuntington Medical Research Institutes · USUniversity of California, Irvine · USUniversity of Southern California · USJohns Hopkins University · US

Funding

Cognitive challenge to reveal systemic neurophysiology biomarkers in pre-symptomatic Alzheimer’s diseaseR01AG063857 · NIA · HUNTINGTON MEDICAL RESEARCH INSTITUTES · PI ARAKAKI, XIANGHONG, KLONER, ROBERT A · 2021 to 2025
$3.8M
Cognitive challenge to reveal presymptomatic Alzheimer's diseaseR56AG063857 · NIA · HUNTINGTON MEDICAL RESEARCH INSTITUTES · PI ARAKAKI, XIANGHONG, HARRINGTON, MICHAEL GORDON · 2019 to 2019
$513k
NIA NIH HHS R01 AG063857NIA NIH HHS R56 AG063857
6 · The paper itself

Abstract

Electroencephalographic (EEG) alpha oscillations have been related to heart rate variability (HRV) and both change in Alzheimer's disease (AD). We explored if task switching reveals altered alpha power and HRV in cognitively healthy individuals with AD pathology in cerebrospinal fluid (CSF) and whether HRV improves the AD pathology classification by alpha power alone. We compared low and high alpha event-related desynchronization (ERD) and HRV parameters during task switch testing between two groups of cognitively healthy participants classified by CSF amyloid/tau ratio: normal (CH-NAT, n = 19) or pathological (CH-PAT, n = 27). For the task switching paradigm, participants were required to name the color or word for each colored word stimulus, with two sequential stimuli per trial. Trials include color (cC) or word (wW) repeats with low load repeating, and word (cW) or color switch (wC) for high load switching. HRV was assessed for RR interval, standard deviation of RR-intervals (SDNN) and root mean squared successive differences (RMSSD) in time domain, and low frequency (LF), high frequency (HF), and LF/HF ratio in frequency domain. Results showed that CH-PATs compared to CH-NATs presented: 1) increased (less negative) low alpha ERD during low load repeat trials and lower word switch cost (low alpha: p = 0.008, Cohen's d = -0.83, 95% confidence interval -1.44 to -0.22, and high alpha: p = 0.019, Cohen's d = -0.73, 95% confidence interval -1.34 to -0.13); 2) decreasing HRV from rest to task, suggesting hyper-activated sympatho-vagal responses. 3) CH-PATs classification by alpha ERD was improved by supplementing HRV signatures, supporting a potentially compromised brain-heart interoceptive regulation in CH-PATs. Further experiments are needed to validate these findings for clinical significance.

Indexed as

Alzheimer DiseaseBrainElectroencephalographyHeart RateHumansPilot ProjectsAlpha event-related desynchronization (ERD)Alzheimer's disease (AD)Cognitively healthy with normal (CH-NAT) or pathological (CH-PAT) cerebrospinal fluid (CSF) amyloid/tauElectroencephalography (EEG)Task switching

Identifiers

PMID34666107
PMCPMC8865562
OpenAlexW3205589991

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.